EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Development and external validation of two nomograms for predicting brain metastases and brain metastasis-free survival in primary small cell carcinoma of the esophagus: a retrospective multicenter analysis

Liang Yi iD, Wei Huang, Qifeng Wang iD, Qingwu Du, Cihui Yan, Yaowen Zhang, Wenbin Shen, Xiaolin Ge, Ning Yang, Xiujun Su, Feng Wang, Jian Zhang und 3 weitere

Therapeutic Advances in Medical Oncology · 2026-08 · 18

DOI: 10.1177/17588359261469564 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Advances in Medical Oncology, online erschienen am 04.08.2026. Verfasst von Liang Yi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laborat…. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Reliably predicting brain metastasis (BM) and brain metastasis‑free survival (BMFS) in patients with primary small cell carcinoma of the esophagus (PSCCE) remains a clinical challenge.

Objectives

To develop and externally validate predictive nomograms for assessing BM probability and BMFS in patients with PSCCE.

Design

A retrospective model development and external validation study.

Methods

Using a training cohort, we constructed two separate nomograms. The first was developed using univariable and multivariable logistic regression to predict the probability of BM. The second was built using a Fine‑Gray competing-risk model to estimate BMFS, treating death without BM as a competing event. The performance of both nomograms was evaluated using the area under the receiver operating characteristic (ROC) curve/time-dependent ROC curve, calibration plots, and decision curve analysis (DCA). External validation was subsequently performed using an independent validation cohort.

Results

The study sample included 492 patients in the training cohort (mean age at diagnosis 61.97 ± 8.86 years; 133 (27%) female) and 344 patients in the external validation cohort (mean age at diagnosis 62.97 ± 8.14 years; 108 (31%) female). Age, N stage, and M stage emerged as independent predictors and were included in a nomogram to estimate BM risk. Adding lesion length and initial treatments (radiotherapy, chemotherapy, and surgery) to these three factors allowed the model to predict BMFS. Both nomograms showed strong predictive performance in the training cohort, with area under the ROC curve values of 0.76 and 0.843, respectively, supported by calibration plots and DCA. These results were confirmed in the external validation cohort. The logistic regression‑based nomogram accurately predicted BM probability, while the Fine–Gray model provided reliable estimates of BMFS.

Conclusion

We successfully developed and externally validated two complementary nomograms that reliably predict BM probability and BMFS in patients with PSCCE. These tools may aid in risk stratification and inform personalized surveillance strategies.

Schlagwörter

Stichwörter der Autor:innen

brain metastasiscarcinomaesophageal neoplasmsnomogramprediction modelprophylactic cranial irradiation (PCI)small cell

Autor:innen und Institutionen

  • Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Cent…
  • Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China.
  • Department of Radiation Oncology, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Radiation Oncology Key Laboratory of Sichuan…
  • Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for C…
  • Department of Radiotherapy, Anyang Cancer Hospital, The Fourth Affiliated Hospital of Henan University of Science and Technology, Anyang, China.
  • Department of Radiotherapy, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.

ORCID-Profile: Liang Yi, Qifeng Wang, Meng Wang

Zitieren

APA

Yi, L., Huang, W., Wang, Q., Du, Q., Yan, C., Zhang, Y., Shen, W., Ge, X., Yang, N., Su, X., Wang, F., Zhang, J., Zhang, W., Yuan, Z., & Wang, M. (2026). Development and external validation of two nomograms for predicting brain metastases and brain metastasis-free survival in primary small cell carcinoma of the esophagus: a retrospective multicenter analysis. Therapeutic Advances in Medical Oncology, 18. https://doi.org/10.1177/17588359261469564

Vancouver

Yi L, Huang W, Wang Q, Du Q, Yan C, Zhang Y, et al. Development and external validation of two nomograms for predicting brain metastases and brain metastasis-free survival in primary small cell carcinoma of the esophagus: a retrospective multicenter analysis. Therapeutic Advances in Medical Oncology. 2026;18. doi:10.1177/17588359261469564

BibTeX
@article{Yi2026,
  author = {Yi, Liang and Huang, Wei and Wang, Qifeng and Du, Qingwu and Yan, Cihui and Zhang, Yaowen and Shen, Wenbin and Ge, Xiaolin and Yang, Ning and Su, Xiujun and Wang, Feng and Zhang, Jian and Zhang, Wencheng and Yuan, Zhiyong and Wang, Meng},
  title = {Development and external validation of two nomograms for predicting brain metastases and brain metastasis-free survival in primary small cell carcinoma of the esophagus: a retrospective multicenter analysis},
  journal = {Therapeutic Advances in Medical Oncology},
  year = {2026},
  volume = {18},
  doi = {10.1177/17588359261469564}
}
Kostenlos starten →